Sirona Biochem Corp (SBM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sirona Biochem Corp (SBM) has a cash flow conversion efficiency ratio of 0.160x as of July 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-552.59K ≈ $-399.74K USD) by net assets (CA$-3.46 Million ≈ $-2.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Sirona Biochem Corp (SBM) defensive interval to measure how many days the company can operate on defensive assets alone.
Sirona Biochem Corp - Cash Flow Conversion Efficiency Trend (2011–2023)
This chart illustrates how Sirona Biochem Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Sirona Biochem Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sirona Biochem Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Reliance Chemotex Industries Limited
NSE:RELCHEMQ
|
0.036x |
|
Dycasa SA
BA:DYCA
|
-0.135x |
|
Jet Freight Logistics Limited
NSE:JETFREIGHT
|
0.076x |
|
reAlpha Tech Corp. Common Stock
NASDAQ:AIRE
|
-0.335x |
|
InnSuites Hospitality Trust
NYSE MKT:IHT
|
0.988x |
|
CBL International Limited Ordinary Shares
NASDAQ:BANL
|
-0.025x |
|
Gurktaler Aktiengesellschaft
VI:GAGV
|
N/A |
|
AUGA GROUP AB EO 029
F:W9Z
|
0.032x |
Annual Cash Flow Conversion Efficiency for Sirona Biochem Corp (2011–2023)
The table below shows the annual cash flow conversion efficiency of Sirona Biochem Corp from 2011 to 2023. For the full company profile with market capitalisation and key ratios, see SBM market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-10-31 | CA$-2.51 Million ≈ $-1.82 Million |
CA$-1.76 Million ≈ $-1.27 Million |
0.700x | +106.89% |
| 2022-10-31 | CA$214.51K ≈ $155.18K |
CA$-2.18 Million ≈ $-1.58 Million |
-10.151x | -145.63% |
| 2021-10-31 | CA$-97.02K ≈ $-70.18K |
CA$-2.16 Million ≈ $-1.56 Million |
22.246x | +149.92% |
| 2020-10-31 | CA$47.40K ≈ $34.28K |
CA$-2.11 Million ≈ $-1.53 Million |
-44.564x | -2641.24% |
| 2019-10-31 | CA$2.19 Million ≈ $1.58 Million |
CA$-3.56 Million ≈ $-2.57 Million |
-1.626x | -719.47% |
| 2018-10-31 | CA$-2.26 Million ≈ $-1.64 Million |
CA$-593.35K ≈ $-429.22K |
0.262x | -78.57% |
| 2017-10-31 | CA$-2.04 Million ≈ $-1.48 Million |
CA$-2.50 Million ≈ $-1.81 Million |
1.225x | +191.01% |
| 2016-10-31 | CA$1.56 Million ≈ $1.13 Million |
CA$-2.10 Million ≈ $-1.52 Million |
-1.346x | +5.71% |
| 2015-10-31 | CA$2.15 Million ≈ $1.55 Million |
CA$-3.06 Million ≈ $-2.22 Million |
-1.427x | -37.36% |
| 2014-10-31 | CA$1.79 Million ≈ $1.30 Million |
CA$-1.86 Million ≈ $-1.35 Million |
-1.039x | +10.78% |
| 2013-10-31 | CA$2.15 Million ≈ $1.55 Million |
CA$-2.50 Million ≈ $-1.81 Million |
-1.164x | +7.70% |
| 2012-10-31 | CA$1.70 Million ≈ $1.23 Million |
CA$-2.15 Million ≈ $-1.55 Million |
-1.261x | -35.27% |
| 2011-10-31 | CA$2.72 Million ≈ $1.97 Million |
CA$-2.54 Million ≈ $-1.84 Million |
-0.933x | -- |
About Sirona Biochem Corp
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, engages in the development and sale of cosmetic and pharmaceutical active ingredients in Canada and France. The company's programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, anti-wrinkle compound, and anti-viral program. The company … Read more